SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-08-000006
Filing Date
2008-05-09
Accepted
2008-05-09 13:53:35
Documents
1
Period of Report
2008-05-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 2934
  Complete submission text file 0000886163-08-000006.txt   4765
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address C/O LIGAND PHARMACEUTICALS INC 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121 858-550-7577
MEGLASSON MARTIN (Reporting) CIK: 0001280564 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 08817516